0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics

Buy Now

High-Risk Breast Cancer - Diagnosis (Paperback, Softcover reprint of the original 1st ed. 1989) Loot Price: R3,006
Discovery Miles 30 060
High-Risk Breast Cancer - Diagnosis (Paperback, Softcover reprint of the original 1st ed. 1989): Joseph Ragaz, Irving M Ariel

High-Risk Breast Cancer - Diagnosis (Paperback, Softcover reprint of the original 1st ed. 1989)

Joseph Ragaz, Irving M Ariel

 (sign in to rate)
Loot Price R3,006 Discovery Miles 30 060 | Repayment Terms: R282 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The most meaningful reward to clinicians and researchers is the absence of recurrent malignancy in their patients. While in some patients the disease will be cured by resection alone, in other similarly staged cases the disease will recur despite adequate loco regional and systemic therapies. Hence, risk assessment is a complex issue with many related or unrelated prognostic factors determining outcome. The purpose of this volume is to review some of the most relevant prognostic factors of newly diagnosed breast cancer, focusing on fea tures determining the magnitude of risk. The ultimate value of establishing the significance of each prognostic factor in a given patient will be the resulting ability to plan individu alized therapies for patients at different risk of recurrence at the time of diagnosis. To secure the maximum benefit for high-risk patients, while avoiding undue toxicity in those with low-risk lesions, a well-integrated analysis of all known prognostic factors will be essential in the early postdiagnos tic period. In addition to well-established staging criteria such as axillary nodes, tumor size, receptors, scanning and radiographic examinations, the more sophisticated labora tory techniques, as discussed by several authors herein, will playa crucial role in risk assessment. Most of them, - ploidy determination, oncogenes, tumor markers, monoclonal anti bodies, growth factors, etc. -are presently available in only a minority of treatment centers.

General

Imprint: Springer-Verlag
Country of origin: Germany
Release date: December 2011
First published: 1989
Editors: Joseph Ragaz • Irving M Ariel
Dimensions: 242 x 170 x 21mm (L x W x T)
Format: Paperback
Pages: 383
Edition: Softcover reprint of the original 1st ed. 1989
ISBN-13: 978-3-642-73720-6
Categories: Books > Medicine > Surgery > General surgery
Books > Medicine > Clinical & internal medicine > Gynaecology & obstetrics > General
Books > Medicine > Other branches of medicine > Medical imaging > Radiology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 3-642-73720-X
Barcode: 9783642737206

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners